Cyclosporine
Cyclosporine is a powerful immune-suppressing medication used to prevent organ rejection after transplants and to treat severe rheumatoid arthritis and psoriasis.
🧬 Where this information comes from Click to expand
The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 11 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →
⚠️ FDA Boxed Warning — the FDA’s strongest safety alert ▾
Cyclosporine carries serious risks that require expert medical supervision. Because it suppresses the immune system, it can make you significantly more vulnerable to infections and raise your risk of developing lymphoma (a blood cancer) or other cancers — especially when used alongside other immunosuppressive drugs after a transplant.
Cyclosporine also comes in different formulations that are not interchangeable — switching between them without a doctor's guidance can cause your blood levels to be too high (leading to toxicity) or too low (risking organ rejection). Blood levels must be monitored regularly. This medication should only be prescribed and managed by physicians specifically experienced in immunosuppressive therapy, and patients should be cared for at facilities with the proper monitoring resources.
📖 Cyclosporine: Patient Information Guide
A plain-language walkthrough of Cyclosporine — what it treats, how it works, how it’s taken, side effects, warnings and interactions. Tap any section to expand it.
🎯What it's used for▾
Cyclosporine is used for several serious conditions where the immune system needs to be kept in check:
- Organ transplantation — prevents rejection after kidney, liver, or heart transplants, often combined with other immunosuppressive drugs
- Rheumatoid arthritis — for severe, active cases that haven't responded adequately to methotrexate alone
- Severe plaque psoriasis — for adults with extensive or disabling psoriasis who have tried and failed other systemic treatments, or for whom those treatments aren't an option
⚙️How it works▾
Cyclosporine targets specific immune cells called T-lymphocytes — particularly the T-helper cells that direct immune attacks. It blocks these cells at an early stage of their growth cycle, preventing them from multiplying and from releasing inflammatory proteins like interleukin-2. The result is a controlled dampening of the immune response: enough to stop the body from attacking a transplanted organ or inflamed tissue, but without shutting down functions like the infection-fighting activity of other immune cells such as macrophages.
Importantly, cyclosporine does not suppress the bone marrow, which means it doesn't cause the blood cell production problems seen with some other immunosuppressants. Its effects are specific and reversible — targeting the immune overreaction rather than broadly wiping out immune function.
💊How it's taken▾
Cyclosporine is taken by mouth, either as a capsule or a liquid solution, typically twice daily. It's critical to take it at the same times every day and to keep your routine consistent around meals — if you normally take it with food, always take it with food.
- The liquid solution can be mixed with orange juice or apple juice (not grapefruit juice)
- Avoid all grapefruit and grapefruit juice — they raise cyclosporine blood levels and can cause toxicity
- Do not switch between the modified and non-modified formulations without your doctor's supervision — they are not interchangeable
- If you miss a dose, contact your care team for guidance rather than doubling up
🤒Side effects — in detail▾
Cyclosporine has a number of side effects that your doctor will monitor for during treatment:
- Kidney function changes (the most common and important concern)
- High blood pressure
- Tremor or shaking
- Increased hair growth on the body
- Gum overgrowth (gums may become swollen or enlarged)
- Low magnesium levels in the blood
- Elevated liver enzymes
Serious reactions — including significant kidney damage, new infections, signs of cancer, or seizures — require immediate medical attention. Don't wait to call your doctor if something feels wrong.
⚠️Warnings & precautions▾
- Kidney damage: Cyclosporine can cause serious, sometimes permanent kidney damage. This risk increases with higher doses and longer use. Serum creatinine is monitored regularly to catch problems early.
- Increased infection risk: Because the immune system is suppressed, even common infections can become serious. Report any fever, chills, or unusual symptoms promptly.
- Cancer risk: Long-term immune suppression raises the risk of lymphoma and other cancers, especially when multiple immunosuppressive agents are used together.
- Liver toxicity: Cyclosporine can also harm the liver, particularly at higher doses. Liver function is monitored throughout treatment.
- Formulation mix-up risk: The modified formulation (this drug) and older Sandimmune formulations are NOT interchangeable — swapping them can cause blood levels to be too high or too low, with serious consequences.
🔀What it interacts with▾
Cyclosporine interacts with many drugs and foods — always keep your entire care team updated on everything you take:
- Grapefruit and grapefruit juice — blocks the enzyme that clears cyclosporine, raising blood levels to potentially toxic amounts
- Methotrexate — cyclosporine significantly increases methotrexate levels in the blood, raising toxicity risk
- Diclofenac (an NSAID pain reliever) — blood levels of diclofenac are notably increased when taken with cyclosporine
- Nephrotoxic drugs (kidney-harming medications) — combining these with cyclosporine compounds kidney damage risk
- Other immunosuppressants — using them together further raises the risk of serious infections and cancer
- PUVA, UVB light, coal tar, and radiation therapy — absolutely must not be used together with cyclosporine in psoriasis patients
This is not a complete list of interactions. Always talk with your doctor or pharmacist before starting, stopping, or changing any medication.
📋Before taking it▾
- Anyone with abnormal kidney function should discuss this carefully with their doctor — cyclosporine can worsen it; rheumatoid arthritis and psoriasis patients with kidney problems generally should not take it
- People with uncontrolled high blood pressure should not take cyclosporine for RA or psoriasis until it's controlled
- Anyone with a current or past cancer (malignancy) should tell their doctor before starting
- Older adults require especially close monitoring because kidney function naturally declines with age
- People with severe liver disease may need dose adjustments since the liver processes cyclosporine
- Tell your doctor about all medications, including over-the-counter drugs and supplements
- Anyone with a known allergy to cyclosporine or any ingredient in the formulation must not take it
🚑If you take too much▾
Taking too much cyclosporine can cause vomiting, drowsiness, headache, rapid heartbeat, and temporary kidney or liver problems. If an overdose is suspected, call the Poison Help line at 1-800-222-1222 right away. Cyclosporine is not effectively removed by dialysis or activated charcoal, so getting expert guidance quickly matters.
📡Pharmacodynamics — effects in the body▾
Cyclosporine selectively suppresses the immune system by inhibiting T-lymphocytes — especially T-helper cells — at an early stage of their activation cycle. It blocks the production and release of interleukin-2 and other immune-signaling proteins (lymphokines) that would otherwise drive immune attacks on transplanted organs or inflamed tissue. Notably, it does not affect the bone marrow and does not impair the phagocytic (pathogen-engulfing) activity of other immune cells, making its immune suppression more targeted than some alternatives.
🔬Pharmacokinetics — how your body processes it▾
After taking cyclosporine by mouth, absorption is incomplete and varies quite a bit from person to person and between formulations. The body processes it primarily through the liver, and it is eliminated mainly through bile into the stool — only about 6% leaves the body through urine. The drug has a half-life (the time for blood levels to fall by half) of roughly 8 to 18 hours. Because absorption varies so much between individuals, blood level monitoring is essential to ensure the dose is in the right range — not too low (risking rejection or treatment failure) and not too high (risking toxicity).
📦How to store it▾
Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) 100 mg — Off-white, oblong, soft gelatin capsules. Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) Store and Dispense In the original container at 20° to 25…
📄 Written from Cyclosporine’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Every point is grounded in that labeling — nothing is invented. How we use AI →
Supplements & herbs that interact with Cyclosporine
229 supplements and herbal products have documented interactions with Cyclosporine in the licensed clinical database we use. Most are manageable — but your pharmacist should know about everything you take, including vitamins and herbals.
- Major · 9
- Moderate · 182
- Minor · 38
Educational information from a licensed clinical database (Natural Medicines) — see our data sources & update cadence. Not medical advice: an interaction being documented does not mean it will happen to you; do not start or stop medications or supplements without professional guidance.
Nutrient depletion considerations
Cyclosporine has been associated with lower levels of 1 nutrient in the clinical literature. This does not mean a deficiency will occur — it means these may be worth discussing with your pharmacist or healthcare provider, especially with long-term use.
Educational information from a licensed clinical database (Natural Medicines) — not medical advice. Do not start or stop medications or supplements without professional guidance.
🩺 Pharmacist Counseling Corner
Quick, plain-English answers to the questions patients ask most about Cyclosporine — the kind of thing our pharmacy team would talk through with you at the counter.
Why do I need blood tests so often while taking cyclosporine? ▾
Can I eat grapefruit while taking cyclosporine? ▾
My skin is getting hairier and my gums look swollen — is this from cyclosporine? ▾
Does cyclosporine make me more likely to get sick? ▾
I was told not to switch between cyclosporine brands. Why does that matter? ▾
Can I take over-the-counter pain relievers like ibuprofen or naproxen while on cyclosporine? ▾
Is Cyclosporine available over the counter? ▾
When was Cyclosporine first available? ▾
Who makes Cyclosporine? ▾
💬 Answers drafted from Cyclosporine’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Grounded in that labeling — nothing is made up. How we use AI →
🧰 Keep exploring
💊 How Cyclosporine comes
Cyclosporine is available in 4 forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Capsule
Eye drops
Oral solution
Injection
📊 Cyclosporine across the U.S. market
How Cyclosporine appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
Also listed with the FDA, not a patient dose form: Powder (23) — bulk drug substance sold to compounders/manufacturers and multi-item kits. These aren’t counted in the dose-form total above.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
📈 How widely Cyclosporine is used
A general measure of how commonly Cyclosporine is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.
Think of this as a proxy for how widely Cyclosporine is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.
How commonly is Cyclosporine prescribed? Of the 1,596 medications we measure, Cyclosporine ranks #287 by Medicaid prescriptions — more than 82% of them.
Utilization by Cyclosporine product
Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.
0.4 ML cyclosporine 0.5 MG/ML Ophthalmic Suspension Most dispensed
Summed across the 12 of 28 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 2572292
cyclosporine 0.9 MG/ML Ophthalmic Solution
Summed across the 1 of 2 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 2055021
cyclosporine, modified 25 MG Oral Capsule
Summed across the 4 of 14 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 835894
cyclosporine 1 MG/ML Ophthalmic Solution
Summed across the 1 of 2 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 2639936
cyclosporine, modified 100 MG Oral Capsule
Summed across the 5 of 12 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 241834
cyclosporine 0.5 MG/ML Ophthalmic Suspension
Summed across the 1 of 3 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 351291
cyclosporine 100 MG Oral Capsule
Summed across the 2 of 11 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 328160
cyclosporine 25 MG Oral Capsule
Summed across the 2 of 10 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 197553
cyclosporine, modified 50 MG Oral Capsule
Summed across the 2 of 5 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 835925
cyclosporine, modified 100 MG/ML Oral Solution
Summed across the 1 of 2 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 835886
cyclosporine 1 MG/ML Ophthalmic Suspension
Summed across the 1 of 5 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 2590608
Other Cyclosporine products — combination packs and listings not yet matched to a specific clinical product (kept visible so every prescription is accounted for)
Summed across the 1 of 45 listed NDC products with Medicaid activity.
Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.
Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Cyclosporine, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 33 of 139 listed Cyclosporine NDCs with Medicaid activity.
🔍 Compare Cyclosporine products
A representative set of FDA-listed product records for Cyclosporine — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Capsule | ||||
| 25 mg | Oral | AbbVie Inc. × 2 listings | ANDA | View NDC → |
| 100 mg | Oral | AbbVie Inc. × 2 listings | ANDA | View NDC → |
| 25 mg | Oral | American Health Packaging × 2 listings | ANDA | View NDC → |
| 100 mg | Oral | American Health Packaging × 2 listings | ANDA | View NDC → |
| 25 mg | Oral | Apotex Corp. × 6 listings | ANDA | View NDC → |
| 50 mg | Oral | Apotex Corp. × 3 listings | ANDA | View NDC → |
| 100 mg | Oral | Apotex Corp. × 6 listings | ANDA | View NDC → |
| 25 mg | — | Catalent Pharma Solutions, LLC | EXPORT ONLY | View NDC → |
| 25 mg | — | Catalent Pharma Solutions, LLC × 2 listings | DRUG FOR FURTHER PROCESSING | View NDC → |
| 100 mg | — | Catalent Pharma Solutions, LLC × 3 listings | DRUG FOR FURTHER PROCESSING | View NDC → |
| 25 mg | Oral | Dr. Reddy's Laboratories Inc | ANDA | View NDC → |
| 100 mg | Oral | Dr. Reddy's Laboratories Inc | ANDA | View NDC → |
| 25 mg | Oral | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. × 2 listings | ANDA | View NDC → |
| 50 mg | Oral | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. × 2 listings | ANDA | View NDC → |
| 100 mg | Oral | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. × 2 listings | ANDA | View NDC → |
| 25 mg | Oral | Mayne Pharma Inc. | ANDA | View NDC → |
| 100 mg | Oral | Mayne Pharma Inc. | ANDA | View NDC → |
| 25 mg | Oral | Novartis Pharmaceuticals Corporation × 9 listings | NDA | View NDC → |
| 100 mg | Oral | Novartis Pharmaceuticals Corporation × 9 listings | NDA | View NDC → |
| 25 mg | — | Patheon Softgels Inc | DRUG FOR FURTHER PROCESSING | View NDC → |
| 100 mg | — | Patheon Softgels Inc | DRUG FOR FURTHER PROCESSING | View NDC → |
| 25 mg | Oral | Strides Pharma Science Limited × 3 listings | ANDA | View NDC → |
| 50 mg | Oral | Strides Pharma Science Limited × 3 listings | ANDA | View NDC → |
| 100 mg | Oral | Strides Pharma Science Limited × 3 listings | ANDA | View NDC → |
| 25 mg | Oral | Teva Pharmaceuticals USA, Inc. × 3 listings | ANDA | View NDC → |
| 50 mg | Oral | Teva Pharmaceuticals USA, Inc. × 3 listings | ANDA | View NDC → |
| 100 mg | Oral | Teva Pharmaceuticals USA, Inc. × 3 listings | ANDA | View NDC → |
| 💊Eye drops | ||||
| 0.5 mg/mL | Ophthalmic | A-S Medication Solutions × 3 listings | NDA | View NDC → |
| 0.5 mg/mL | Ophthalmic | A-S Medication Solutions | NDA AUTHORIZED GENERIC | Find on DailyMed ↗ |
| 0.5 mg/mL | Ophthalmic | Allergan, Inc. × 6 listings | NDA | View NDC → |
| 0.5 mg/mL | Ophthalmic | Amneal Pharmaceuticals NY LLC | ANDA | View NDC → |
| 0.5 mg/mL | Ophthalmic | Apotex Corp × 3 listings | NDA AUTHORIZED GENERIC | View NDC → |
| 0.5 mg/mL | Ophthalmic | Devatis Inc. | ANDA | View NDC → |
| 1 mg/mL | Ophthalmic, Topical | Harrow Eye, LLC | NDA | View NDC → |
| 1 mg/mL | Ophthalmic | Harrow Eye, LLC × 2 listings | NDA | View NDC → |
| 0.5 mg/mL | Ophthalmic | Kvk-tech, Inc. × 3 listings | NDA AUTHORIZED GENERIC | View NDC → |
| 0.5 mg/mL | Ophthalmic | Lupin Pharmaceuticals, Inc. × 3 listings | NDA AUTHORIZED GENERIC | View NDC → |
| 0.5 mg/mL | Ophthalmic | Mylan Pharmaceuticals Inc. | ANDA | View NDC → |
| 1 mg/mL | Ophthalmic | Novaliq GmbH | NDA | View NDC → |
| 1 mg/mL | Ophthalmic, Topical | Santen Incorporated | NDA | View NDC → |
| 1 mg/mL | Ophthalmic; Topical | Santen Incorporated × 2 listings | NDA | View NDC → |
| 0.5 mg/mL | Ophthalmic | Saptalis Pharmaceuticals, LLC | ANDA | View NDC → |
| 0.0009 mg/mL | Ophthalmic, Topical | Sun Pharmaceutical Industries, Inc. × 2 listings | NDA | View NDC → |
| 0.0009 mg/mL | Ophthalmic; Topical | Sun Pharmaceutical Industries, Inc. × 2 listings | NDA | View NDC → |
| 0.0009 g/mL | Ophthalmic, Topical | Sun Pharmaceutical Industries, Inc. × 2 listings | NDA | View NDC → |
| 0.0009 g/mL | Ophthalmic; Topical | Sun Pharmaceutical Industries, Inc. × 2 listings | NDA | View NDC → |
| 0.5 mg/mL | Ophthalmic | Teva Pharmaceuticals, Inc. | ANDA | View NDC → |
| 0.5 mg/mL | Ophthalmic | Upsher-Smith Laboratories, LLC | ANDA | View NDC → |
| 💊Injection | ||||
| 50 mg/mL | Intravenous | Bryant Ranch Prepack × 2 listings | ANDA | View NDC → |
| 50 mg/mL | Intravenous | Novartis Pharmaceuticals Corporation × 4 listings | NDA | View NDC → |
| 50 mg/mL | — | Novartis Pharma Stein AG | DRUG FOR FURTHER PROCESSING | View NDC → |
| 50 mg/mL | Intravenous | Padagis US LLC × 2 listings | ANDA | View NDC → |
| 💊Oral solution | ||||
| 100 mg/mL | Oral | AbbVie Inc. | ANDA | View NDC → |
| 100 mg/mL | Oral | Novartis Pharmaceuticals Corporation × 7 listings | NDA | View NDC → |
| 100 mg/mL | Oral | Teva Pharmaceuticals USA, Inc. × 2 listings | ANDA | View NDC → |
| 💊Bulk drug substance | ||||
| 1 kg/kg | — | AbbVie Inc. | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | CKD Bio Corporation | BULK INGREDIENT | View NDC → |
| 1 mg/mg | — | Concord Biotech Limited | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Concord Biotech Limited | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Curia Italy s.r.l | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Curia Italy S.r.l. × 3 listings | BULK INGREDIENT | View NDC → |
| 1 g/g | — | Darmerica, LLC | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Fujian Kerui Pharmaceutical Co., Ltd. | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Joyang Laboratories × 3 listings | BULK INGREDIENT | View NDC → |
| 1 g/g | — | Kalchem International Inc | BULK INGREDIENT | View NDC → |
| 1 g/g | — | Letco Medical, Llc | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING | View NDC → |
| 1 g/g | — | Medisca Inc. | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING | View NDC → |
| 1 kg/kg | — | North China Pharmaceutical Huasheng Co. Ltd. | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Professional Compounding Centers Of America × 2 listings | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING | View NDC → |
| 100 kg/100 kg | — | TAPI Czech Industries s.r.o. | BULK INGREDIENT | View NDC → |
| 100 kg/100 kg | — | Teva Czech Industries s.r.o | BULK INGREDIENT | View NDC → |
| 1 g/g | — | Zhejiang Ruibang Laboratories | BULK INGREDIENT | View NDC → |
Showing 159 of 159 products — FDA National Drug Code Directory. See every product, package size and price: browse all 159 Cyclosporine NDCs →
📈 What people report — real-world data (FDA FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Cyclosporine — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Cyclosporine in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
🏛️ The road to your pharmacy
How Cyclosporine went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
🚨 Recall history
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
Source: openFDA drug enforcement (recall) reports.
RxNorm Concept Web — From Ingredient to Every Form and Strength
This page starts with one ingredient concept (IN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). Combination products remain separate concepts with their own pages.
RxCUI 3008 6 dose forms · 16 strengths
-
Dose form (SCDF) Injection RxCUI 1732364In current FDA listingsClinical drug / strength (SCD) 5 ML cyclosporine 50 MG/MLRxCUI 205175 -
Dose form (SCDF) Ophthalmic Ointment RxCUI 1093173No current FDA listingClinical drug / strength (SCD) 0.002 MG/MGRxCUI 1093174 -
Dose form (SCDF) Ophthalmic Solution RxCUI 2055020In current FDA listings -
Dose form (SCDF) Ophthalmic Suspension RxCUI 378766In current FDA listingsClinical drug / strength (SCD) 0.4 ML cyclosporine 0.5 MG/MLRxCUI 25722920.5 MG/MLRxCUI 3512911 MG/MLRxCUI 2590608 -
Dose form (SCDF) Oral Capsule RxCUI 371666In current FDA listingsClinical drug / strength (SCD) modified 10 MGRxCUI 835919modified 100 MGRxCUI 241834modified 25 MGRxCUI 835894modified 50 MGRxCUI 83592525 MGRxCUI 19755350 MGRxCUI 205168100 MGRxCUI 328160 -
Dose form (SCDF) Oral Solution RxCUI 371667In current FDA listings
Look up RxCUI 3008 in the RxCUI Atlas →
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
📦 Supply & shortage status
Whether Cyclosporine is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
🏷️ Sold under these brand names
🏭 Manufacturers & labelers
…and 16 more on the FDA NDC directory.
RxNorm drug class
Cyclosporine belongs to the Calcineurin Inhibitor Immunosuppressant class.
Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.
🔬 Where this comes from
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How we combine label and product data
HelloPharmacist combines public FDA and NLM records; we don’t author the underlying clinical facts. We identified 11 FDA-filed SPL label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. The representative label is the starting point for the displayed reference monograph; the 12 largest stored in-scope SPL records, which may include that representative, are compared section by section, and the longest available version of each section is retained. Forms, routes, brands, labelers, product-listed strengths, and product-record counts are aggregated separately from ingredient-matched FDA NDC Directory records; package records listed above are associated with the linked SPL; and the normalized concept hierarchy comes from NLM RxNorm.
For canonical ingredient pages, bounded product-attributed indication and administration excerpts may be added to the AI evidence, and the generator is instructed to preserve available product, brand, route, and form qualifiers instead of treating one label as universal. Where a section is identified as AI-written, its plain-language text is generated from bounded label evidence. New draft drug pages remain in the admin review queue before first publication. Novartis Pharmaceuticals Corporation is the representative DailyMed label linked for verification and dates; it is not the sole source used for the page.
This is general education, not medical advice — always consult your doctor or pharmacist about your medications and any medical condition. For the exact wording of the linked representative label, view that label on DailyMed; some displayed composite sections may come from other in-scope SPL labels. Learn how we use AI and our data sources & update cadence.